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Chaharmahal va Bakhtiari province in the southwest of Iran. 
 Study Design: In this experimental study, mutations in 3 ex-
ons, namely exons 2, 3 and 4, of  VSX1 were investigated in 50 
patients with KC and 50 healthy control subjects. DNA was 
extracted using a standard phenol-chloroform method. PCR-
single-strand conformational polymorphism/heteroduplex 
analysis was performed, followed by DNA sequencing to 
confirm the identified motility shifts.  Results: H244R muta-
tions were found in 1 patient and also in 1 healthy control 
subject. Furthermore, 12 polymorphisms were identified in 
patients with KC and 7 in healthy control subjects [rs6138482 
and c.546A>G (rs12480307)].  Conclusion: Our investigation 
showed that KC-related  VSX1 mutations were found in a very 
small proportion of the studied patients from Iran. Further 
investigations on other genes are needed to clarify their 
roles in KC pathogenesis.  © 2013 S. Karger AG, Basel
 Key Words
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 Abstract
 Objective: Keratoconus (KC) is an eye disorder in which the 
cornea is swollen, thinned and deformed. Despite extensive 
studies, the pathophysiological processes and genetic etiol-
ogy of KC are unknown. The disease incidence is approxi-
mately 1 in 2,000, and it is the most common cause of cor-
neal transplantation in the USA. Many genes are involved in 
the disease, but evidence suggests a major role for  VSX1 in 
the etiology of KC. This study aimed to determine the fre-
quency of mutations in exons 2, 3 and 4 of the  VSX1 gene in 
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 Introduction
 Keratoconus (KC) is a disorder in which the cornea 
becomes swollen, thinned and deformed. KC is associat-
ed with astigmatism and classically progresses until the 
third or fourth decade of life. In advanced cases of the 
disease, corneal scarring causes a further decrease in the 
visual resolution. Symptoms are different depending on 
the stage of the disease  [1, 2] . Disease prevalence is almost 
1 in 2,000. KC is involved in 34.5% of corneal transplant 
cases. Therefore, it is the most common cause of corneal 
transplantation in the USA  [3] . Despite extensive studies, 
the pathophysiological processes and genetic etiology of 
KC are unknown  [4] . Some evidence suggests that the 
gene  VSX1 (located on 20p11.2, MIM 605020) is involved 
in the etiology of KC.  VSX1 is a developmental gene re-
garded as significant in ocular development and is usu-
ally expressed in the developing cornea.  VSX1 mRNA has 
been discovered in the outer tier of the inner nuclear lay-
er of the human retina, embryonic craniofacial tissue and 
the cornea  [5] . The gene has 5 exons spanning 6.2 kb of 
coding sequence  [6] . Some genetic variants of the  VSX1 
 gene  [6–8] have been identified in different parts of the 
world, but a definite pathogenic role of the genetic vari-
ants in causation of KC has not yet been confirmed. There 
is no accurate statistical information regarding the preva-
lence of KC. However, it has been deduced to have a high 
prevalence due to its association with spring conjunctivi-
tis. It is more prevalent in men than in women  [9] . KC is 
distinct from other eye diseases in that it affects the indi-
vidual in young age, leading to decreased quality of life 
 [10–12] . While KC is normally observed as autosomal 
dominant inheritance with reduced penetrance  [13] , an 
autosomal recessive mode of inheritance has been ob-
served in consanguineous marriages  [14] . Finally, multi-
factorial patterns have also been reported  [15] . So far, sev-
eral chromosomal loci and genes have been suggested to 
be associated with KC  [10, 16] . Of course, some genes 
were eventually excluded  [16, 17] , some showed no con-
firmed association with the disease  [3, 4] and finally some 
genes, such as the visual system homebox 1  (VSX1) gene, 
have been proved to cause KC in different studies  [18–
21] . There are also studies which failed to find any  VSX1 
 mutations in cohorts of KC patients from different popu-
lations  [21, 22] . This might suggest that KC is a heteroge-
neous disorder. Multifactorial inheritance is another ex-
planation.
 The present study was aimed at determining the type 
and frequency of  VSX1 gene mutations in exons 2, 3 and 
4 of Iranian patients with KC, using PCR-single-strand 
conformational polymorphism (SSCP)/heteroduplex 
analysis (HA) followed by DNA sequencing, because pre-
vious studies showed increased probability of  VSX1  mu-
tations in these exons  [23] .
 Materials and Methods
 Subjects
 In total, 50 healthy control subjects and 50 sporadic cases of 
KC, including 30 males and 20 females, were recruited from 
Shahrekord University Hospital and included in this study. Diag-
nosis of KC was based on clinical examinations and the presence 
of characteristic topographic features. Informed consent for par-
ticipation was signed by all the study subjects. The study protocol 
was approved by the Clinical Research Ethics Committee of the 
Shahrekord University of Medical Sciences.
 Sampling and Molecular Studies
 Five milliliters of whole blood was collected in 0.5  M EDTA-
containing tubes. The genomic DNA was extracted with a phenol-
chloroform method  [24] . Forward and reverse primers for exons 
2, 3 and 4 of the  VSX1 gene were designed using Primer 3 software 
(http://frodo.wi.mit.edu/). The positive control samples for exons 
2, 3 and 4 were created using PCR-mediated site-directed muta-
genesis using FM * and reverse primers ( table 1 ). Because the PCR 
product of exons 3 and 4 is great, we would have a maximum ef-
ficiency of the PCR-SSCP technique products with sizes of 150–
350 bp for exons of the two primer pairs  [25–27] .
 The PCR amplification was performed in a total volume of 25 μl 
of mixture containing the following: 100 ng of genomic DNA, 1.0 
 Table 1.  Sequences of primers used in the study
 Primer 
name 
 Fragment 
size,
 bp 
 Type of 
primer 
 Primer sequence (5′ → 3′) 
 V2  208  F
 R
 FM* 
 ATAGAGGGGATATGATCACC
 ATAAACCTTGGGCTGTGTC
 ATAGAGGGGATATGAGCACC 
 V3/1  245  F
 R
 FM* 
 TGTGTGTTTTGGGGTCCT
 GTTGGCTATAGAGAAGGGAC
 TGTGTGTTTTGGGGCCCT 
 V3/2  293  F
 R
 FM* 
 CGTGTCATTCCCACATTCA
 TCTCCTCAGGCATTTGTG
 CGTGTCATTCCCACGCTCA 
 V4/1  241  F
 R
 FM* 
 TACTGCGTTGAATGCCCGT
 TGAAACCAGACCTGGTTGG
 TACTGCGTTGAATGACCGT 
 V4/2  263  F
 R
 FM* 
 TGTGTGCCTTCTGCTTCTCC
 CACCTCCTACAACACCTCGA
 TGTGTGCCTTCTGCTCCTCC 
 F = Forward; R = reverse; FM* = forward mutation. 
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μ M of each primer, 200 μ M of each dNTP, 2.0 μ M of MgCl 2 , 1.0 U of 
Taq DNA polymerase and 10 μl of Taq buffer (Fermentas) using the 
Astec gradient 96 (Astec, Japan). The thermal cycle profile was as 
follows: initial denaturation at 95   °   C for 3 min, followed by 30–35 
cycles including 95   °   C for 1 min, annealing temperature for 30 s for 
different primers (52–58   °   C) and extension at 72   °   C for 30 s. A final 
extension step followed at 72   °   C for 8 min. All of the PCR products 
were subjected to 8% polyacrylamide gel electrophoresis (PAGE). 
PCR products were visualized by means of silver (AgNO 3 ) staining.
 For SSCP, a mixture of 5 μl of PCR product and 4 μl of denatur-
ing buffer (90% formamide, 10 m M disodium EDTA, 1% xylene 
cyanol and 1% bromophenol blue) was heated at 95   °   C for 15 min 
and then immediately placed on ice to prevent renaturation  [28] .
 For HA, 2.2 μl of PCR product from each sample was mixed 
with 3.2 μl of EDTA (0.5  M ) and heated at 95   °   C for 5 min, then 
slowly cooled to 37   °   C using 60 cycles of 30 s. Samples (5 μl) of each 
denatured PCR product were loaded on nondenaturing PAGE 
(8%) for 1 h at 50 mA (Merck, Germany). The prepared SSCP 
product was mixed with the HA product for each sample and was 
loaded on 8% PAGE. Bands were visualized using a silver staining 
method. Samples with mobility shifts were verified by a second 
independent PCR-SSCP.
 Subsequent DNA sequencing of the PCR-amplified product 
with the motility shift on the gel was carried out bidirectionally on 
an ABI 3130 automated sequencer (Applied Biosystems; Macro-
gen, South Korea) using the same primers.
 Results
 The H244R mutation and 2 polymorphisms, namely 
c.546A>G and c.650G>A, were identified ( table 2 ).
 The mutation H244R is a missense mutation in codon 
244 in exon 4 of  VSX1. It was identified in about 2% of the 
patients and 2% of the healthy control subjects studied. It 
was found by an altered pattern using SSCP/HA ( fig. 1 ). 
The DNA sequencing results confirmed the result ( fig. 2 ).
 The Synonymous Mutation A182A
 In this mutation, a single nucleotide, adenine, was
substituted by guanine at g.25059546 (rs12480307; 
c.546A>G). It affects codon 182, resulting in a synony-
mous change ( fig. 3 ).
 R217H
 In this mutation, a single nucleotide, thymine, was 
substituted by adenine at position g.25059442 (rs6138482; 
c.650T>A), causing codon 217 to change from CGC to 
CAC, resulting in a nonsynonymous mutation ( fig. 4 ).
 This was found by an altered pattern using SSCP/HA 
( fig. 5 ).
 Discussion
 KC is a heterogeneous disorder with variable clinical 
expression. Several hypotheses regarding the etiology of 
KC have been suggested, including biomechanical, envi-
ronmental, genetic and biochemical causes. In spite of an 
enormous amount of research conducted to explain the 
etiology and disease progression,  VSX1 is the sole gene 
indicated as an important genetic factor in determining 
KC. In this study, 3 sequence variations were detected, all 
of which have been previously reported  [3, 4, 18, 29, 30] . 
We found the H244R mutation in exon 4 of the gene; it 
was present in 2% of the patients and 2% of the healthy 
1M 2 3 4 C+ 5 6 7 8 9 10 11 12 13
 Table 2.  Allelic variants in  VSX1 found in this study
 Reference sequence  Exon  Nucleotide change  Protein change  Controls
 (n = 50) 
 Patients
 (n = 50) 
 NM_014588  3  c.546A>G (rs12480307)  p.A182A  4 (8%)  6 (12%) 
 NM_199425  3  c.650G>A (rs6138482)  p.R217H  3 (6%)  6 (12%) 
 NT_011387.8  4  p.H244R  1 (2%)  1 (2%) 
 Fig. 1. SSCP and HA of exon 4 part 2 of the  VSX1 gene. The arrow 
shows a shift in the band motility. Lane M: molecular weight mark-
er (100 bp); lanes 1–13: samples; lane C+: positive control. 
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control subjects, which is concordant with the results of 
other studies  [12, 23, 31–36] ( table 3 ). The H244R variant 
is important as it is 100% conserved from flies to humans. 
It is located in the CVC domain, which is functionally es-
sential for the repressive transcriptional action of  VSX1 
 [21] . Several protein coding changes have been identified 
in the  VSX1 gene sequence, namely L159M, p.D144Ep, 
p.L17P, p.P247R, p.R166W, p.H244R and p.G160D. Oth-
er mutations, such as Asp144Glu and His244Arg, were 
observed in healthy relatives of patients and thus should 
not be pathogenic  [37, 38] .  Also, a study was conducted 
in central Iran, indicating that the H244R mutation was 
co-segregated in affected family members, but not in those 
that were unaffected  [2] . As a result, a defined pathogenic 
role has not been established for either of these mutations 
 [39] . In our study, 2 polymorphisms were found in the 
patients and healthy control subjects. PolyPhen and SIFT 
analyses of p.R217H suggest that it is nonpathogenic 
(SIFT score >0.05 and position-specific independent 
counts score <1.5)  [4] . Similar results have previously 
been reported in European populations  [18] .  VSX1 muta-
tions have been reported in 4.7% (3 of 63)  [40] and 8.75%
 Table 3.  Alterations in the  VSX1 gene in various populations
 Study  Population studied  Origin  Alteration  Frequency 
 Paliwal et al. [35]  66 KC patients  Indian subcontinent  c.525G>C  1.6% 
 Stabuc-Silih et al. [36]  113 patients  Slovenia  627  +  23G.A polymorphism  15% 
 Abu-Amero et al. [12]  55 KC patients,
 50 controls 
 Saudi Arabia  noncoding (g.8326 G>A,
 g.10945 G>T and g.11059 A>C) 
 3.6% 
 synonymous coding
 sequence changes (g.5053 G>T
and g.8222 A>G) 
 5.4% 
 Paliwal et al. [23]  family  India  Q175H mutation  mutation identified in affected 
brother and in the mother 
 Valleix et al. [33]  4 family members  France  H244R mutation  sequence analysis showed that 
the H244R variant in  VSX1 
segregated with corneal and 
macular disease phenotypes in 
this family 
a
b
G G G CCCC
C C C CA
G G G
GGGGG TT
T T
a
b
C C C C C C
C C C C C C
A
G TT T
T TT
a
b
A
A A
A A
AA
C
C
G T T
T
C
C
G
G G
G
T
 Fig. 2. Electropherogram illustrating the 
H244R mutation in exon 4 of the  VSX1 
gene from subjects’ DNA.  a Nucleotide
sequences of a control subject.  b Partial
sequences showing the A>G change in a 
patient. 
 Fig. 3. Electropherogram of the  VSX1  gene 
corresponding to codons 181–184.  a The 
reference sequence derived from a control 
subject.  b Sequence derived from a patient 
showing a heterozygous A>G nucleotide 
change. 
 Fig. 4. Electropherogram of the  VSX1  gene 
corresponding to  codons 217–219.  a The 
reference sequence derived from a control 
subject.  b Sequence derived from a patient 
showing a heterozygous G>A nucleotide 
change which is a nonsynonymous muta-
tion (p.R217H). 
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(7 of 80) of unrelated KC patients  [31] , whereas other 
groups have failed to identify  VSX1 pathogenic sequence 
variants in KC  [3, 29, 39] . Mutations in  VSX1 have also 
been reported in posterior polymorphous corneal dystro-
phy (MIM 122000)  [40] and in combination with KC. Al-
though the pathogenic role of  VSX1 is now accepted by 
many authors, only a small number of patients show mu-
tations in this gene. In addition, several loci for the disease 
have been mapped  [10, 16, 22, 41] , and a large number of 
genes have been shown to be up- or downregulated in KC 
corneal tissues  [42–44] . Reports have confirmed the ge-
netic heterogeneity of the disease and also support the hy-
pothesis that in some pedigrees the defect could be inher-
ited as a multifactorial trait. Some environmental factors 
that can be involved include use of contact lenses, eye rub-
bing, spring conjunctivitis, swelling, occupation and even 
certain seasons of the year  [2] . Thus far, mutations report-
ed in this gene such as p.H244R, p.G160D, p.L159M, 
p.P247R, p.D144E and p.R166W have been reported in 
different ethnic groups, but no definite pathogenic func-
tion has been established for them so far  [40, 45] .
 In summary, in addition to the  VSX1 gene, other genes 
are likely to be involved in the pathogenesis of KC, which 
warrants further investigations.
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 Fig. 5. SSCP and HA of exon 3/1 of the  VSX1 gene. The arrows 
show altered heteroduplex bands in samples 5, 7 and 8, in which 
variants were observed. Lane M: molecular weight marker; lane 1: 
positive control; lanes 2–8: samples.
 References 
 1 Rabinowitz YS: Intacs for keratoconus. Curr 
Opin Ophthalmol 2007;  18:  279–283.
 2 Saee-Rad S, Hashemi H, Miraftab M, Noori-
Daloii MR, Chaleshtori MH, Raoofian R, et al: 
Mutation analysis of VSX1 and SOD1 in Ira-
nian patients with keratoconus. Mol Vis 2011; 
 17:  3128–3136.
 3 Tang YG, Picornell Y, Su X, Li X, Yang H, 
Rabinowitz YS: Three VSX1 gene mutations, 
L159M, R166W, and H244R, are not associ-
ated with keratoconus. Cornea 2008;  27:  189–
192.
 4 Tanwar M, Kumar M, Nayak B, Pathak D, 
Sharma N, Titiyal JS, et al: VSX1 gene analysis 
in keratoconus. Mol Vis 2010;  16:  2395–2401.
 5 Hayashi T, Huang J, Deeb SS: RINX(VSX1), a 
novel homeobox gene expressed in the inner 
nuclear layer of the adult retina. Genomics 
2000;  67:  128–139.
 6 Vincent AL, Jordan C, Sheck L, Niederer R, 
Patel DV, McGhee CN: Screening the visual 
system homeobox 1 gene in keratoconus and 
posterior polymorphous dystrophy cohorts 
identifies a novel variant. Mol Vis 2013;  19: 
 852–860.
 7 Mok JW, Baek SJ, Joo CK: VSX1 gene variants 
are associated with keratoconus in unrelated 
Korean patients. J Hum Genet 2008;  53:  842–
849.
 8 Eran P, Almogit A, David Z, Wolf HR, Hana 
G, Yaniv B, et al: The D144E substitution in 
the VSX1 gene: a non-pathogenic variant or a 
disease causing mutation? Ophthalmic Genet 
2008;  29:  53–59.
 9 Javadi MA, Feizi S, Yazdani S, Sharifi A, Sajja-
di H: Outcomes of augmented relaxing inci-
sions for postpenetrating keratoplasty astig-
matism in keratoconus. Cornea 2009;  28:  280–
284.
 10 Bisceglia L, De Bonis P, Pizzicoli C, Fischetti 
L, Laborante A, Di Perna M, et al: Linkage 
analysis in keratoconus: replication of locus 
5q21. 2 and identification of other suggestive 
Loci. Invest Ophthalmol Vis Sci 2009;  50: 
 1081–1086.
 11 Tang YG, Rabinowitz YS, Taylor KD, Li X, Hu 
M, Picornell Y, et al: Genomewide linkage 
scan in a multigeneration Caucasian pedigree 
identifies a novel locus for keratoconus on 
chromosome 5q14.3–q21.1. Genet Med 2005; 
 7:  397–405.
 12 Abu-Amero KK, Kalantan H, Al-Muammar 
AM: Analysis of the VSX1 gene in keratoco-
nus patients from Saudi Arabia. Mol Vis 2011; 
 17:  667–672.
 13 Mackey DA: Genetic eye research in Tasma-
nia: a historical overview. Clin Experiment 
Ophthalmol 2012;  40:  205–210.
 14 Piñero DP, Nieto JC, Lopez-Miguel A: Charac-
terization of corneal structure in keratoconus. 
J Cataract Refract Surg 2012;  38:  2167–2183.
 15 Francois M, Chassaing N, Calvas P: Genetics 
of keratoconus; in Barbara A (ed): Textbook 
on Keratoconus: New Insights. New Delhi, 
Jaypee Brothers Medical Publishers, 2011, pp 
12–17.
 16 Gajecka M: The genetics of keratoconus; in 
Traboulsi EI (ed): Genetic Diseases of the Eye, 
ed 2. New York, Oxford University Press, 
2012, pp 288–294.
 17 Fullerton J, Paprocki P, Foote S, Mackey DA, 
Williamson R, Forrest S: Identity-by-descent 
approach to gene localisation in eight individ-
uals affected by keratoconus from north-west 
Tasmania, Australia. Hum Genet 2002;  110: 
 462–470.
  Co
lo
r v
er
si
on
 a
va
ila
bl
e 
on
lin
e  
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
ity
 o
f A
la
ba
m
a,
 L
ist
er
 H
ill 
Li
br
ar
y 
   
   
   
   
13
8.
26
.3
1.
3 
- 1
0/
1/
20
13
 7
:0
6:
18
 P
M
 Dehkordi et al.
 
Acta Cytologica
DOI: 10.1159/000353297
6
 18 Dash DP, George S, O’Prey D, Burns D, Nabi-
li S, Donnelly U, et al: Mutational screening of 
VSX1 in keratoconus patients from the Euro-
pean population. Eye (Lond) 2010;  24:  1085–
1092.
 19 Semina EV, Mintz-Hittner HA, Murray JC: 
Isolation and characterization of a novel hu-
man paired-like homeodomain-containing 
transcription factor gene, VSX1, expressed in 
ocular tissues. Genomics 2000;  63:  289–293.
 20 Abu-Amero KK, Kalantan H, Al-Muammar 
AM: Analysis of the VSX1 gene in keratoco-
nus patients from Saudi Arabia. Mol Vis 2011; 
 17:  667–672.
 21 Shi Z, Jervis D, Nickerson PEB, Chow RL: Re-
quirement for the paired-like homeodomain 
transcription factor VSX1 in type 3a mouse 
retinal bipolar cell terminal differentiation. J 
Comp Neurol 2012;  520:  117–129.
 22 Li X, Bykhovskaya Y, Haritunians T, Sisco-
vick D, Aldave A, Szczotka-Flynn L, et al: A 
genome-wide association study identifies a 
potential novel gene locus for keratoconus, 
one of the commonest causes for corneal 
transplantation in developed countries. Hum 
Mol Genet 2012;  21:  421–429.
 23 Paliwal P, Tandon R, Dube D, Kaur P, Sharma 
A: Familial segregation of a VSX1 mutation 
adds a new dimension to its role in the causa-
tion of keratoconus. Mol Vis 2011;  17:  481–
485.
 24 Bakry D, Malkin D: TP53 germline muta-
tions: genetics of Li-Fraumeni syndrome; in 
Hainaut P, Olivier M, Wiman KG (eds): p53 
in the Clinics. New York, Springer, 2013, pp 
167–188.
 25 Sunnucks P, Wilson A, Beheregaray L, Zenger 
K, French J, Taylor A: SSCP is not so difficult: 
the application and utility of single-stranded 
conformation polymorphism in evolutionary 
biology and molecular ecology. Mol Ecol 
2001;  9:  1699–1710.
 26 Dillon DA, Hipolito E, Zheng K, Rimm DL, 
Costa JC: p53 mutations as tumor markers in 
fine needle aspirates of palpable breast mass-
es. Acta Cytol 2011;  46:  841–847.
 27 Ma ES, Ng WK, Wong CL: EGFR gene muta-
tion study in cytology specimens. Acta Cytol 
2012;  56:  661–668.
 28 Krothapalli S, May MK, Hestekin CN: Capil-
lary electrophoresis-single strand conforma-
tion polymorphism for the detection of mul-
tiple mutations leading to tuberculosis drug 
resistance. J Microbiol Methods 2012;  91:  147–
154.
 29 Liskova P, Ebenezer ND, Hysi PG, Gwilliam 
R, El-Ashry MF, Moodaley LC, et al: Molecu-
lar analysis of the VSX1 gene in familial kera-
toconus. Mol Vis 2007;  13:  1887–1891.
 30 Grunauer-Kloevekorn C, Duncker GI: Kera-
toconus: epidemiology, risk factors and diag-
nosis (in German). Klin Monbl Augenheilkd 
2006;  223:  493–502.
 31 Bisceglia L, Ciaschetti M, De Bonis P, Campo 
PAP, Pizzicoli C, Scala C, et al: VSX1 muta-
tional analysis in a series of Italian patients 
affected by keratoconus: detection of a novel 
mutation. Invest Ophthalmol Vis Sci 2005;  46: 
 39–45.
 32 Yellore VS, Rayner SA, Nguyen CK, Ganga-
lum RK, Jing Z, Bhat SP, et al: Analysis of the 
role of ZEB1 in the pathogenesis of posterior 
polymorphous corneal dystrophy. Invest 
Ophthalmol Vis Sci 2012;  53:  273–278.
 33 Valleix S, Nedelec B, Rigaudiere F, Dighiero 
P, Pouliquen Y, Renard G, et al: H244R VSX1 
is associated with selective cone ON bipolar 
cell dysfunction and macular degeneration in 
a PPCD family. Invest Ophthalmol Vis Sci 
2006;  47:  48–54.
 34 Watson T, Chow RL: Absence of Vsx1 expres-
sion in the normal and damaged mouse cor-
nea. Mol Vis 2011;  17:  737–744.
 35 Paliwal P, Singh A, Tandon R, Titiyal JS, Shar-
ma A: A novel VSX1 mutation identified in an 
individual with keratoconus in India. Mol Vis 
2009;  15:  2475–2479.
 36 Stabuc-Silih M, Strazisar M, Hawlina M, 
Glavac D: Absence of pathogenic mutations 
in VSX1 and SOD1 genes in patients with ker-
atoconus. Cornea 2010;  29:  172–176.
 37 Bechara S, Grossniklaus H, Waring G 3rd, 
Wells J 3rd: Keratoconus associated with pos-
terior polymorphous dystrophy. Am J Oph-
thalmol 1991;  112:  729–731.
 38 Blair SD, Seabrooks D, Shields WJ, Pillai S, 
Cavanagh H: Bilateral progressive essential 
iris atrophy and keratoconus with coincident 
features of posterior polymorphous dystro-
phy: a case report and proposed pathogenesis. 
Cornea 1992;  11:  255–261.
 39 Aldave AJ, Yellore VS, Salem AK, Yoo GL, 
Rayner SA, Yang H, et al: No VSX1 gene mu-
tations associated with keratoconus. Invest 
Ophthalmol Vis Sci 2006;  47:  2820–2822.
 40 Heon E, Greenberg A, Kopp KK, Rootman D, 
Vincent AL, Billingsley G, et al: VSX1: a gene 
for posterior polymorphous dystrophy and 
keratoconus. Hum Mol Genet 2002;  11:  1029–
1036.
 41 Liskova P, Hysi PG, Waseem N, Ebenezer 
ND, Bhattacharya SS, Tuft SJ: Evidence for 
keratoconus susceptibility locus on chromo-
some 14: a genome-wide linkage screen using 
single-nucleotide polymorphism markers. 
Arch Ophthalmol 2010;  128:  1191–1195.
 42 Lema I, Duran JA, Ruiz C, Diez-Feijoo E, 
Acera A, Merayo J: Inflammatory response to 
contact lenses in patients with keratoconus 
compared with myopic subjects. Cornea 
2008;  27:  758–763.
 43 Sutton G, Madigan M, Roufas A, McAvoy J: 
Secreted frizzled-related protein 1 (SFRP1) is 
highly upregulated in keratoconus epitheli-
um: a novel finding highlighting a new poten-
tial focus for keratoconus research and treat-
ment. Clin Experiment Ophthalmol 2010;  38: 
 43–48.
 44 Lee JE, Oum BS, Choi HY, Lee SU, Lee JS: 
Evaluation of differentially expressed genes 
identified in keratoconus. Mol Vis 2009;  15: 
 2480–2487.
 45 Hughes AE, Dash DP, Jackson AJ, Frazer DG, 
Silvestri G: Familial keratoconus with cata-
ract: linkage to the long arm of chromosome 
15 and exclusion of candidate genes. Invest 
Ophthalmol Vis Sci 2003;  44:  5063–5066.
 
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
ity
 o
f A
la
ba
m
a,
 L
ist
er
 H
ill 
Li
br
ar
y 
   
   
   
   
13
8.
26
.3
1.
3 
- 1
0/
1/
20
13
 7
:0
6:
18
 P
M
View publication stats
